EGCG, a green tea catechin, attenuates the progression of heart failure induced by the heart/muscle-specific deletion of MnSOD in mice

Journal of Cardiology

Volumn 69, Issue 2, 2017, Pages 417-427

  Oyama, Jun ichi ^a,b   Shiraki, Aya ^a   Nishikido, Toshiyuki ^a   Maeda, Toyoki ^b   Komoda, Hiroshi ^a   Shimizu, Takahiko ^c   Makino, Naoki ^b   Node, Koichi ^a  

^a SAGA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Catechin; EGCG; Heart failure; MnSOD; Oxidative stress

Indexed keywords

3 NITROTYROSINE; DRINKING WATER; EPIGALLOCATECHIN GALLATE; FATTY ACID; FATTY ACID SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; SIRTUIN 1; TELOMERASE; TOLL LIKE RECEPTOR 4; 3-NITROTYROSINE; ANTIOXIDANT; CATECHIN; NOS2 PROTEIN, RAT; SIRT1 PROTEIN, MOUSE; SUPEROXIDE DISMUTASE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG MEGADOSE; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; GENE DELETION; HEART CONTRACTION; HEART DILATATION; HEART FAILURE; HEART MUSCLE CONTRACTILITY; LOW DRUG DOSE; MALE; MORTALITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SURVIVAL RATE; TELOMERE; TELOMERE LENGTH; TELOMERE SHORTENING; ANALOGS AND DERIVATIVES; ANIMAL; CARDIAC MUSCLE; DISEASE MODEL; DRUG EFFECTS; GENETICS; HEART VENTRICLE REMODELING; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; ANTIOXIDANTS; CATECHIN; DISEASE MODELS, ANIMAL; FATTY ACID SYNTHASES; FATTY ACIDS, NONESTERIFIED; HEART FAILURE; MICE; MICE, KNOCKOUT; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; SIRTUIN 1; SUPEROXIDE DISMUTASE; TELOMERASE; TELOMERE SHORTENING; TOLL-LIKE RECEPTOR 4; TYROSINE; VENTRICULAR REMODELING;

EID: 84978481291     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2016.05.019     Document Type: Article

References (55)

1. [1] Liew, C.C., Dzau, V.J., Molecular genetics and genomics of heart failure. Nat Rev Genet 5 (2004), 811–825.
2. [2] Alameddine, F.M., Zafari, A.M., Genetic polymorphisms and oxidative stress in heart failure. Congest Heart Fail 8 (2002), 157–164 172.
3. [3] Givertz, M.M., Colucci, W.S., New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress. Lancet 352:Suppl. 1 (1998), SI34–SI38.
4. [4] Giordano, F.J., Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115 (2005), 500–508.
5. [5] Keith, M., Geranmayegan, A., Sole, M.J., Kurian, R., Robinson, A., Omran, A.S., Jeejeebhoy, K.N., Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31 (1998), 1352–1356.
6. [6] Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J., Tedgui, A., Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97 (1998), 1536–1539.
7. [7] Dieterich, S., Bieligk, U., Beulich, K., Hasenfuss, G., Prestle, J., Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart. Circulation 101 (2000), 33–39.
8. [8] Khaper, N., Kaur, K., Li, T., Farahmand, F., Singal, P.K., Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction. Mol Cell Biochem 251 (2003), 9–15.
9. [9] Li, Y., Huang, T.T., Carlson, E.J., Melov, S., Ursell, P.C., Olson, J.L., Noble, L.J., Yoshimura, M.P., Berger, C., Chan, P.H., Wallace, D.C., Epstein, C.J., Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11 (1995), 376–381.
10. [10] Nojiri, H., Shimizu, T., Funakoshi, M., Yamaguchi, O., Zhou, H., Kawakami, S., Ohta, Y., Sami, M., Tachibana, T., Ishikawa, H., Kurosawa, H., Kahn, R.C., Otsu, K., Shirasawa, T., Oxidative stress causes heart failure with impaired mitochondrial respiration. J Biol Chem 281 (2006), 33789–33801.
11. [11] Ikegami, T., Suzuki, Y., Shimizu, T., Isono, K., Koseki, H., Shirasawa, T., Model mice for tissue-specific deletion of the manganese superoxide dismutase (MnSOD) gene. Biochem Biophys Res Commun 296 (2002), 729–736.
12. [12] Valenti, L., Conte, D., Piperno, A., Dongiovanni, P., Fracanzani, A.L., Fraquelli, M., Vergani, A., Gianni, C., Carmagnola, L., Fargion, S., The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis. J Med Genet 41 (2004), 946–950.
13. [13] Chyu, K.Y., Babbidge, S.M., Zhao, X., Dandillaya, R., Rietveld, A.G., Yano, J., Dimayuga, P., Cercek, B., Shah, P.K., Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 109 (2004), 2448–2453.
14. [14] Kuriyama, S., Shimazu, T., Ohmori, K., Kikuchi, N., Nakaya, N., Nishino, Y., Tsubono, Y., Tsuji, I., Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296 (2006), 1255–1265.
15. [15] Kakoti, B.B., Hernandez-Ontiveros, D.G., Kataki, M.S., Shah, K., Pathak, Y., Panguluri, S.K., Resveratrol and omega-3 fatty acid: its implications in cardiovascular diseases. Front Cardiovasc Med, 2, 2015, 38.
16. [16] Endo, J., Arita, M., Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. J Cardiol 67 (2016), 22–27.
17. [17] Oyama, J., Maeda, T., Sasaki, M., Higuchi, Y., Node, K., Makino, N., Repetitive hyperthermia attenuates progression of left ventricular hypertrophy and increases telomerase activity in hypertensive rats. Am J Physiol Heart Circ Physiol 302 (2012), H2092–H2101.
18. [18] Takamura, C., Suzuki, J.I., Ogawa, M., Watanabe, R., Tada, Y., Maejima, Y., Akazawa, H., Komuro, I., Isobe, M., Suppression of murine autoimmune myocarditis achieved with direct renin inhibition. J Cardiol, 2015 pii:S0914-5087(15)00295-6.
19. [19] Kuwahara, H., Horie, T., Ishikawa, S., Tsuda, C., Kawakami, S., Noda, Y., Kaneko, T., Tahara, S., Tachibana, T., Okabe, M., Melki, J., Takano, R., Toda, T., Morikawa, D., Nojiri, H., et al. Oxidative stress in skeletal muscle causes severe disturbance of exercise activity without muscle atrophy. Free Radic Biol Med 48 (2010), 1252–1262.
20. [20] Griendling, K.K., FitzGerald, G.A., Oxidative stress and cardiovascular injury. Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108 (2003), 1912–1916.
21. [21] Dhalla, N.S., Temsah, R.M., Netticadan, T., Role of oxidative stress in cardiovascular diseases. J Hypertens 18 (2000), 655–673.
22. [22] Oyama, J., Shimokawa, H., Momii, H., Cheng, X., Fukuyama, N., Arai, Y., Egashira, K., Nakazawa, H., Takeshita, A., Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Clin Invest 101 (1998), 2207–2214.
23. [23] Frantz, S., Kobzik, L., Kim, Y.D., Fukazawa, R., Medzhitov, R., Lee, R.T., Kelly, R.A., Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 104 (1999), 271–280.
24. [24] Oyama, J., Blais, C. Jr., Liu, X., Pu, M., Kobzik, L., Kelly, R.A., Bourcier, T., Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109 (2004), 784–789.
25. [25] Byun, E.B., Choi, H.G., Sung, N.Y., Byun, E.H., Green tea polyphenol epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa laminin receptor on lipopolysaccharide-stimulated dendritic cells. Biochem Biophys Res Commun 426 (2012), 480–485.
26. [26] Hong Byun, E., Fujimura, Y., Yamada, K., Tachibana, H., TLR4 signaling inhibitory pathway induced by green tea polyphenol epigallocatechin-3-gallate through 67-kDa laminin receptor. J Immunol 185 (2010), 33–45.
27. [27] Garlanda, C., Bottazzi, B., Bastone, A., Mantovani, A., Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23 (2005), 337–366.
28. [28] Kotooka, N., Inoue, T., Aoki, S., Anan, M., Komoda, H., Node, K., Prognostic value of pentraxin 3 in patients with chronic heart failure. Int J Cardiol 130 (2008), 19–22.
29. [29] Kim, J.A., Formoso, G., Li, Y., Potenza, M.A., Marasciulo, F.L., Montagnani, M., Quon, M.J., Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem 282 (2007), 13736–13745.
30. [30] Lorenz, M., Wessler, S., Follmann, E., Michaelis, W., Düsterhöft, T., Baumann, G., Stangl, K., Stangl, V., A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 279 (2004), 6190–6195.
31. [31] Oyama, J., Maeda, T., Kouzuma, K., Ochiai, R., Tokimitsu, I., Higuchi, Y., Sugano, M., Makino, N., Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers. Circ J 74 (2010), 578–588.
32. [32] Mohri, M., Egashira, K., Tagawa, T., Kuga, T., Tagawa, H., Harasawa, Y., Shimokawa, H., Takeshita, A., Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure. Hypertension 30 (1997), 50–56.
33. [33] Kubota, T., Imaizumi, T., Oyama, J., Ando, S., Takeshita, A., L-Arginine increases exercise-induced vasodilation of the forearm in patients with heart failure. Jpn Circ J 61 (1997), 471–480.
34. [34] Arts, I.C., Hollman, P.C., Feskens, E.J., Bueno de Mesquita, H.B., Kromhout, D., Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr 74 (2001), 227–232.
35. [35] Mukamal, K.J., Maclure, M., Muller, J.E., Sherwood, J.B., Mittleman, M.A., Tea consumption and mortality after acute myocardial infarction. Circulation 105 (2002), 2476–2481.
36. [36] Tijburg, L.B., Wiseman, S.A., Meijer, G.W., Weststrate, J.A., Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis 135 (1997), 37–47.
37. [37] Takishima, I., Nakamura, T., Hirano, M., Kitta, Y., Kobayashi, T., Fujioka, D., Saito, Y., Watanabe, K., Watanabe, Y., Mishina, H., Obata, J.E., Kawabata, K., Tamaru, S., Kugiyama, K., Predictive value of serial assessment of endothelial function in chronic heart failure. Int J Cardiol 158 (2012), 417–422.
38. [38] Øie, E., Ueland, T., Dahl, C.P., Bohov, P., Berge, C., Yndestad, A., Gullestad, L., Aukrust, P., Berge, R.K., Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality. J Intern Med 270 (2011), 263–272.
39. [39] Tuunanen, H., Engblom, E., Naum, A., Någren, K., Hesse, B., Airaksinen, K.E., Nuutila, P., Iozzo, P., Ukkonen, H., Opie, L.H., Knuuti, J., Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 114 (2006), 2130–2137.
40. [40] Lommi, J., Kupari, M., Yki-Järvinen, H., Free fatty acid kinetics and oxidation in congestive heart failure. Am J Cardiol 81 (1998), 45–50.
41. [41] Li, Y., Zhao, S., Zhang, W., Zhao, P., He, B., Wu, N., Han, P., Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo. Diabetes Res Clin Pract 93 (2011), 205–214.
42. [42] Raederstorff, D.G., Schlachter, M.F., Elste, V., Weber, P., Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 14 (2003), 326–332.
43. [43] Huang, C.H., Tsai, S.J., Wang, Y.J., Pan, M.H., Kao, J.Y., Way, T.D., EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells. Mol Nutr Food Res 53 (2009), 1156–1165.
44. [44] Fuster, J.J., Andre's, V., Telomere biology and cardiovascular disease. Circ Res 99 (2006), 1167–1180.
45. [45] Demissie, S., Levy, D., Benjamin, E.J., Cupples, L.A., Gardner, J.P., Herbert, A., Kimura, M., Larson, M.G., Meigs, J.B., Keaney, J.F., Aviv, A., Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham heart study. Aging Cell 5 (2006), 325–330.
46. [46] Serrano, A.L., Andres, V., Telomeres and cardiovascular disease. Does size matter?. Circ Res 94 (2004), 575–584.
47. [47] Prowse, K.R., Greider, C.W., Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 92 (1995), 4818–4822.
48. [48] Makino, N., Maeda, T., Oyama, J., Sasaki, M., Higuchi, Y., Mimori, K., Shimizu, T., Antioxidant therapy attenuates myocardial telomerase activity reduction in superoxide dismutase-deficient mice. J Mol Cell Cardiol 50 (2010), 670–677.
49. [49] Tanno, M., Kuno, A., Yano, T., Miura, T., Hisahara, S., Ishikawa, S., Shimamoto, K., Horio, Y., Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285 (2010), 8375–8382.
50. [50] Haendeler, J., Hoffmann, J., Brandes, R.P., Zeiher, A.M., Dimmeler, S., Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine. Mol Cell Biol 23 (2003), 4598–4610.
51. [51] Haendeler, J., Hoffmann, J., Diehl, J.F., Vasa, M., Spyridopoulos, I., Zeiher, A.M., Dimmeler, S., Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 94 (2004), 768–775.
52. [52] Alcendor, R.R., Kirshenbaum, L.A., Imai, S., Sadoshima, J., Sir2, a longevity factor and a class III histone deacetylase, is an essential endogenous inhibitor of apoptosis in cardiac myocytes. Circ Res 65 (2004), 971–980.
53. [53] Alcendor, R.R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S.F., Sadoshima, J., Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100 (2007), 1512–1521.
54. [54] Devika, P.T., Stanely Mainzen Prince, P., Protective effect of (−)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: a histopathological study. Biomed Pharmacother 62 (2008), 701–708.
55. [55] Oh, H., Taffet, G.E., Youker, K.A., Entman, M.L., Overbeek, P.A., Michael, L.H., Schneider, M.D., Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci USA 98 (2001), 10308–10313.